贝伐单抗
医学
中止
复发性呼吸道乳头状瘤病
重症监护医学
候选资格
加药
内科学
疾病
化疗
政治学
政治
法学
作者
Simon R. Best,Jonathan M. Bock,Nicole B. Fowler,Eric H. Raabe,Adam M. Klein,Theodore W. Laetsch,Kim McClellan,Rico N. P. M. Rinkel,Nabil F. Saba,Douglas R. Sidell,James B. Tansey,David E. Tunkel,Geoffrey D. Young,Karen B. Zur
出处
期刊:Laryngoscope
[Wiley]
日期:2024-08-03
卷期号:134 (12): 5041-5046
被引量:3
摘要
To provide detailed guidance on the administration of systemic bevacizumab in patients with recurrent respiratory papillomatosis (RRP) based on a detailed review of the scientific literature and a consensus of experts with real-world clinical experience.
科研通智能强力驱动
Strongly Powered by AbleSci AI